Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.656, 2012-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Abciximab for high-risk patients: effective at a cost
Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. :
Access to resources
Recommend
Abciximab for high-risk patients: effective at a cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 287, 2000-01 ,pp. :
SES cost effective in high-risk patients in Canada
Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. :
Iodixanol cost effective vs iohexol among high-risk patients
Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. :
Preventing GI complications only cost effective in patients at risk
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 462, 2004-01 ,pp. :